Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

DocGo (DCGO) EBIT: 2021-2025

Historic EBIT for DocGo (DCGO) over the last 5 years, with Q3 2025 value amounting to -$42.0 million.

  • DocGo's EBIT fell 51407.38% to -$42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$80.9 million, marking a year-over-year decrease of 26917.78%. This contributed to the annual value of $28.7 million for FY2024, which is 9055.97% up from last year.
  • DocGo's EBIT amounted to -$42.0 million in Q3 2025, which was down 51407.38% from -$17.5 million recorded in Q2 2025.
  • In the past 5 years, DocGo's EBIT ranged from a high of $15.9 million in Q1 2024 and a low of -$42.0 million during Q3 2025
  • Moreover, its 5-year median value for EBIT was $1.6 million (2023), whereas its average is $393612.8.
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 1447094.46% in 2023, then tumbled by 51407.38% in 2025.
  • Quarter analysis of 5 years shows DocGo's EBIT stood at $15.5 million in 2021, then crashed by 99.48% to $80116.0 in 2022, then surged by 14470.94% to $11.7 million in 2023, then tumbled by 164.02% to -$7.5 million in 2024, then crashed by 461.69% to -$42.0 million in 2025.
  • Its EBIT stands at -$42.0 million for Q3 2025, versus -$17.5 million for Q2 2025 and -$14.0 million for Q1 2025.